Showing 501 - 520 results of 2,945 for search '"hepatitis"', query time: 0.06s Refine Results
  1. 501
  2. 502
  3. 503
  4. 504

    Capacity Enhancement of Hepatitis C Virus Treatment through Integrated, Community-Based Care by Warren D Hill, Gail Butt, Maria Alvarez, Mel Krajden

    Published 2008-01-01
    “…BACKGROUND: An estimated 250,000 Canadians are infected with the hepatitis C virus (HCV). The present study describes a cohort of individuals with HCV referred to community-based, integrated prevention and care projects developed in British Columbia. …”
    Get full text
    Article
  5. 505

    Cost-effectiveness of Triple Therapy with Telaprevir for Chronic Hepatitis C Virus Patients in Germany by Jona T. Stahmeyer, Svenja Schauer, Siegbert Rossol, Hans Heinrich Wedemeyer, Daniel Wirth, Florence Bianic, Christian Krauth

    Published 2013-12-01
    “…**Background:** About 400,000-500,000 people are infected with hepatitis C in Germany. Long-term consequences are the development of liver cirrhosis and hepatocellular carcinoma. …”
    Get full text
    Article
  6. 506

    Middle hepatic vein incorporation in live donor liver graft transplantation; implication and safety by Mahmoud Ali Abdi, Tayeb Sabir Kareem, Assad Abidon Hassoun

    Published 2021-08-01
    “…The recipient age (48.5 ± 11.3), male/female 27/13, intensive care unit stay (4.75 ± 3.9), floor stay (7.7 ± 3.7) days, portal vein velocity (63.96 ± 24.65 ml/sec), hepatic artery peak systolic velocity (74.76 ± 32.85) hepatic artery resistive index (0.7 ± 0.15), and triphasic/continuous venous outflow 27/13.   …”
    Get full text
    Article
  7. 507

    Serological and Molecular Characterization of the Hepatitis B Virus in Blood Donors in Maputo City, Mozambique by Olga Maquessene, Osvaldo Laurindo, Lúcia Chambal, Nalia Ismael, Nédio Mabunda

    Published 2025-01-01
    “…Hepatitis B virus (HBV) is a major public health concern responsible for hepatitis and hepatocellular carcinoma (HCC) worldwide. …”
    Get full text
    Article
  8. 508

    Viral Response to Specifically Targeted Antiviral Therapy for Hepatitis C and the Implications for Treatment Success by Curtis L Cooper

    Published 2010-01-01
    “…Currently, hepatitis C virus (HCV) antiviral therapy is characterized by long duration, a multitude of side effects, difficult administration and suboptimal success; clearly, alternatives are needed. …”
    Get full text
    Article
  9. 509

    Unveiling the mystery of hepatic epithelioid angiomyolipoma: A unique case report with literature review by Da Teng, Yue Xu, Qingtao Meng, Qingsong Yang

    Published 2025-01-01
    “…Hepatic epithelioid angiomyolipoma is a rare mesenchymal liver tumor within the perivascular epithelioid cell tumor family, known for its uncertain malignancy and potential for aggressive behavior. …”
    Get full text
    Article
  10. 510

    Direct-Acting Antivirals for the Treatment of Chronic Hepatitis C: Open Issues and Future Perspectives by Hee Bok Chae, Seon Mee Park, Sei Jin Youn

    Published 2013-01-01
    “…Currently, two direct-acting antivirals (DAAs) show well-established efficacy against hepatitis C virus (HCV), namely, first-wave protease inhibitors telaprevir and boceprevir. …”
    Get full text
    Article
  11. 511
  12. 512

    Factors Associated with Spontaneous Clearance of Hepatitis C Virus among Illicit Drug Users by Jason Grebely, Jesse D Raffa, Calvin Lai, Mel Krajden, Brian Conway, Mark W Tyndall

    Published 2007-01-01
    “…BACKGROUND: Spontaneous clearance of hepatitis C virus (HCV) occurs in approximately 25% of individuals.…”
    Get full text
    Article
  13. 513

    Hepatitis B Stigma and Knowledge among Vietnamese in Ho Chi Minh City and Chicago by Lan Dam, Anita Cheng, Phuong Tran, Shirley S. Wong, Ronald Hershow, Sheldon Cotler, Scott J. Cotler

    Published 2016-01-01
    “…Stigma regarding viral hepatitis and liver disease has psychological and social consequences including causing negative self-image, disrupting relationships, and providing a barrier to prevention, testing, and treatment. …”
    Get full text
    Article
  14. 514
  15. 515
  16. 516

    Drug-induced autoimmune-like hepatitis: A disproportionality analysis based on the FAERS database. by Wangyu Ye, Yuan Ding, Meng Li, Zhihua Tian, Shaoli Wang, Zhen Liu

    Published 2025-01-01
    “…<h4>Background</h4>Drug-induced autoimmune-like hepatitis (DI-ALH) is a potentially life-threatening condition that can lead to acute liver failure and necessitate liver transplantation. …”
    Get full text
    Article
  17. 517

    Primary Prophylaxis to Prevent the Development of Hepatic Encephalopathy in Cirrhotic Patients with Acute Variceal Bleeding by Fátima Higuera-de-la-Tijera, Alfredo I. Servín-Caamaño, Francisco Salas-Gordillo, José L. Pérez-Hernández, Juan M. Abdo-Francis, Jaime Camacho-Aguilera, Sai N. Alla, Fiacro Jiménez-Ponce

    Published 2018-01-01
    “…Variceal bleeding is the second most important precipitating factor related to the development of episodic hepatic encephalopathy; but to date there are no recommendations to prevent this complication. …”
    Get full text
    Article
  18. 518
  19. 519
  20. 520